Vanguard Fiduciary Trust
IBO

Vanguard Fiduciary Trust’s Impact BioMedical IBO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio IBO Stock Details IBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Buy
589,428
+4,230
+0.7% +$2.5K ﹤0.01% 3479
2026
Q1 		$351K Buy
+585,198
New +$293K ﹤0.01% 3331

Other funds holding IBO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
MAC
Mason & Associates (California) Los Angeles, California $619M AUM 29.44% 1-Year Est. Return

Vanguard Fiduciary Trust's IBO Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Impact BioMedical (IBO) stake by 0.72% in Q2 2026, buying an estimated $2.5K and bringing the position to 589,428 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #3479.

Vanguard Fiduciary Trust first reported a position in IBO in Q1 2026 and has held it in 2 quarters since. The position peaked at $351K in Q1 2026. 21 funds tracked by Wall St. Rank hold IBO as of Q2 2026.

  • Vanguard Fiduciary Trust held 589,428 shares of Impact BioMedical worth $271K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 4,230 Impact BioMedical shares in Q2 2026, an estimated $2.5K.
  • Impact BioMedical made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3479 holding.
  • Vanguard Fiduciary Trust first reported a position in Impact BioMedical in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Impact BioMedical position peaked at $351K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held Impact BioMedical as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.